ausea and vomiting Survey during mild emetic antineoplastic drug combination(doublet study)
Not Applicable
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000018470
- Lead Sponsor
- Donan oncology supportive care study group(DOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who experienced vomiting within chemotherapy before 24 hours 2.Day2 later also cases to use a mild emetic of anti-cancer drugs (except the oral anti-cancer agent) 3.Cases that enforce radiation therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete Response
- Secondary Outcome Measures
Name Time Method Complete Control,Total Control